P. Nelli

484 total citations
29 papers, 377 citations indexed

About

P. Nelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, P. Nelli has authored 29 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in P. Nelli's work include Cancer Treatment and Pharmacology (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Lung Cancer Research Studies (5 papers). P. Nelli is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Lung Cancer Research Studies (5 papers). P. Nelli collaborates with scholars based in Italy, United Kingdom and India. P. Nelli's co-authors include Marco Colleoni, Giovanni Vicario, Roberto Buzzoni, Emilio Bajetta, Franco Nolè, Luigi Celio, Fernando Gaion, Nicoletta Zilembo, Angelo Di Leo and Claudio Graiff and has published in prestigious journals such as Cancer, British Journal of Cancer and Annals of Oncology.

In The Last Decade

P. Nelli

29 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Nelli Italy 10 213 142 99 68 57 29 377
R. J. Rieker Germany 9 130 0.6× 184 1.3× 35 0.4× 40 0.6× 26 0.5× 16 405
Mark Karwal United States 9 147 0.7× 53 0.4× 114 1.2× 57 0.8× 8 0.1× 26 330
Hong Cen China 8 128 0.6× 94 0.7× 26 0.3× 22 0.3× 28 0.5× 16 348
Tetsuo Ohta Japan 10 314 1.5× 149 1.0× 108 1.1× 15 0.2× 17 0.3× 14 452
Manoj Shah India 11 163 0.8× 112 0.8× 42 0.4× 37 0.5× 11 0.2× 29 346
Yoshinari Matsuda Japan 11 132 0.6× 89 0.6× 37 0.4× 39 0.6× 6 0.1× 22 314
Motohisa Takami Japan 8 139 0.7× 113 0.8× 39 0.4× 35 0.5× 8 0.1× 17 413
Sotaro Otake Japan 12 104 0.5× 140 1.0× 27 0.3× 45 0.7× 19 0.3× 17 354
Jean‐Marc Verdebout Belgium 9 316 1.5× 303 2.1× 145 1.5× 7 0.1× 27 0.5× 21 484
Matthew Lumley United Kingdom 7 94 0.4× 19 0.1× 54 0.5× 14 0.2× 61 1.1× 9 304

Countries citing papers authored by P. Nelli

Since Specialization
Citations

This map shows the geographic impact of P. Nelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Nelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Nelli more than expected).

Fields of papers citing papers by P. Nelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Nelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Nelli. The network helps show where P. Nelli may publish in the future.

Co-authorship network of co-authors of P. Nelli

This figure shows the co-authorship network connecting the top 25 collaborators of P. Nelli. A scholar is included among the top collaborators of P. Nelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Nelli. P. Nelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colleoni, Marco, et al.. (1997). Activity of Combination Chemotherapy in Brain Metastases from Breast and Lung Adenocarcinoma. American Journal of Clinical Oncology. 20(3). 303–307. 20 indexed citations
2.
Colleoni, Marco, et al.. (1997). Phase II Study of Estramustine, Oral Etoposide, and Vinorelbine in Hormone-Refractory Prostate Cancer. American Journal of Clinical Oncology. 20(4). 383–386. 35 indexed citations
3.
Colleoni, Marco, et al.. (1997). Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinoma. European Journal of Cancer. 33(1). 56–60. 6 indexed citations
4.
Colleoni, Marco, et al.. (1997). Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolization. Oncology Reports. 4(5). 1025–8. 3 indexed citations
5.
Colleoni, Marco, et al.. (1997). A randomized phase II trial of cisplatinum plus mitomycin-C plus vinorelbine and carboplatin plus vinorelbine in advanced non-small cell lung cancer. International Journal of Oncology. 10(3). 619–22. 6 indexed citations
6.
Colleoni, Marco, Luca Boni, Giovanni Vicario, et al.. (1996). A Dose-Escalating Study of Carboplatin Combined with Vinorelbine in Non-Small-Cell Lung Cancer. Oncology. 53(5). 364–368. 9 indexed citations
7.
Colleoni, Marco, et al.. (1996). Intermittent continuous infusion of fluorouracil, low-dose oral leucovorin and oral etoposide in advanced gastric cancer. Oncology Reports. 3(6). 1169–72. 2 indexed citations
8.
Colleoni, Marco, et al.. (1996). Weekly carboplatin in elderly patients with advanced ovarian cancer. Oncology Reports. 3(2). 277–9. 1 indexed citations
9.
Colleoni, Marco, et al.. (1996). Carboplatin and vinorelbine in elderly patients with non-small cell lung cancer. Oncology Reports. 3(6). 1035–8. 5 indexed citations
10.
Colleoni, Marco, et al.. (1996). Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.. PubMed. 16(5B). 3101–4. 1 indexed citations
11.
Colleoni, Marco, et al.. (1996). Megestrol acetate in unresectable hepatocellular carcinoma.. PubMed. 81(5). 351–3. 6 indexed citations
12.
Colleoni, Marco, F Sartori, Francesco Calabrò, et al.. (1996). Surgery Followed by Intracavitary plus Systemic Chemotherapy in Malignant Pleural Mesothelioma. Tumori Journal. 82(1). 53–56. 29 indexed citations
13.
Colleoni, Marco, et al.. (1995). Mitoxantrone, Fluorouracil plus <i>L</i>-Leucovorin, and Vinorelbine in Pretreated Advanced Breast Cancer. Oncology. 52(6). 435–438. 3 indexed citations
14.
Colleoni, Marco, et al.. (1995). Pain at Tumor Site after Vinorelbine Injection: Description of an Unexpected Side Effect. Tumori Journal. 81(3). 194–196. 9 indexed citations
15.
Colleoni, Marco, et al.. (1995). Megestrol Acetate in Unresectable Hepatocellular Carcinoma. Tumori Journal. 81(5). 351–353. 9 indexed citations
16.
Buzzoni, Roberto, Marco Colleoni, P. Nelli, Franco Nolè, & Emilio Bajetta. (1994). Results of a Salvage Regimen in Refractory or Relapsed Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 14(1-2). 121–128. 36 indexed citations
17.
Bajetta, Emilio, Nicoletta Zilembo, Maria Di Bartolomeo, et al.. (1993). Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group. Cancer. 72(10). 3099–3105. 107 indexed citations
18.
Colleoni, Marco, Emilio Bajetta, P. Nelli, et al.. (1993). Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: The experience of the National Cancer Institute of Milan. Annals of Oncology. 4(6). 489–493. 11 indexed citations
19.
Buzzoni, Roberto, Marco Colleoni, Emilio Bajetta, et al.. (1993). Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma. Annals of Oncology. 4(3). 251–253. 11 indexed citations
20.
Colleoni, Marco, et al.. (1992). Reversal of Resistance to Doxifluridine and Fluorouracil in Metastatic Colorectal Cancer: The Role of High-Dose Folinic Acid. Tumori Journal. 78(4). 258–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026